Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Immunoglobin A nephropathy (also known as IgAN or Berger's disease) is a rare kidney disease that occurs when ...

IgA nephropathy, also known as Berger’s disease, is a progressive, autoimmune, chronic kidney disease that predominantly affects adults between the ages of 20 and 40.

IgA nephropathy is the leading cause of kidney failure. Around half of those with IgA nephropathy will see worsening kidney function over many years. For some people, this happens more quickly.

What is IgA nephropathy?IgA nephropathy (also known as Berger’s disease) is a kidney disorder caused by the buildup of ...

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential. Earlier in June, Vera Therapeutics announced positive topline results from its ongoing ...

Panelists discuss how treatment sequencing in immunoglobulin A (IgA) nephropathy will likely evolve toward a risk-stratified approach, beginning with optimized supportive care and renin ...

Pathogenesis of IgA Nephropathy: The 4-Hit Cascade, A Proliferation-Inducing Ligand (APRIL), and cytokines. EP: 4.Diagnosing IgA Nephropathy. EP: 5.Signs and Symptoms of IgA Nephropathy.

Andrew S. Bomback, MD, MPH, recalls a patient from over a decade ago, who traveled to New York for a second opinion on his IgA nephropathy diagnosis. The patient had researched his condition and ...

IgA nephropathy can be challenging, but a support system makes it easier to manage. Learn how to take steps to stay connected to your community when dealing with this disease.

Source Reference: Heerspink HJL, et al "Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial" Lancet 2023 ...

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses the major risk factors for IgA nephropathy.

Pietro A. Canetta, MD, recounts how, as a young nephrologist at Columbia University, he was encouraged by a mentor to give a talk on IgA nephropathy, a topic that at the time had limited research ...